Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Investigating the Survival of HP802-247 Allogeneic Cells in Excisional Acute Cutaneous Wounds

NCT01190865 is registered in ClinicalTrials.gov with Healthpoint as lead sponsor.

NCT NCT01190865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01190865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Investigating the Survival of HP802-247 Allogeneic Cells in Excisional Acute Cutaneous Wounds
Lead sponsor
Healthpoint
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2010
Completion date
December 31, 2010
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

normal female volunteers